=============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
AUGUST 12, 2002
Date of report (date of earliest event reported)
QUADRAMED CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware 0-21031 52-1992861
------------------------------------------------------------------------------
(State or Other (Commission File Number) (IRS Employer
Jurisdiction Identification No.)
of Incorporation)
------------------------------------------------------------------------------
22 PELICAN WAY, SAN RAFAEL, CALIFORNIA 94901
(Address of Principal Executive Offices) (Zip Code)
(415) 482-2100
(Registrant's Telephone Number, Including Area Code)
ITEM 5. Other Items.
QuadraMed Corporation ("QuadraMed") announced today that it will restate
its previously filed consolidated financial statements for the fiscal years
ending December 31, 2001 and 2000 and for the period ending March 31, 2002.
ITEM 7. Exhibit.
Exhibit No. Description
99.1 QuadraMed Press Release dated August 12, 2002
entitled, "QuadraMed To File For Extension For Form
10-Q."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: August 12, 2002 QUADRAMED CORPORATION
By: /s/ Michael H. Lanza
-----------------------------
Michael H. Lanza
Executive Vice President and
Corporate Secretary